# Use of DurAVR™ THV System in Subjects With Severe Aortic Stenosis: Early Feasibility Study

> **NCT05712161** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Anteris Technologies Ltd.** · enrollment: 15 (actual)

## Conditions studied

- Aortic Stenosis
- Symptomatic Aortic Stenosis
- Severe Aortic Valve Stenosis
- Aortic Valve Calcification

## Interventions

- **DEVICE:** DurAVRTM THV System

## Key facts

- **NCT ID:** NCT05712161
- **Lead sponsor:** Anteris Technologies Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-08-07
- **Primary completion:** 2023-12-29
- **Final completion:** 2033-12
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2026-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05712161

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05712161, "Use of DurAVR™ THV System in Subjects With Severe Aortic Stenosis: Early Feasibility Study". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05712161. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*